HCC1937 Cells

HCC1937 is a human breast carcinoma cell line derived from a primary tumor of an adult female. This cell line exhibits several genetic alterations characteristic of aggressive breast cancer phenotypes, including a homozygous mutation in the BRCA1 gene (5382C mutation), which is a notable marker for predisposition to breast cancer. The presence of this mutation aligns with a familial pattern of breast cancer as it is also detected in other family members, indicating a hereditary aspect to the malignancy. Additionally, HCC1937 has an acquired mutation in the TP53 gene coupled with the loss of the wild-type allele, further compounding its tumor suppressor deficiencies. The cell line also displays a homozygous deletion of the PTEN gene and exhibits loss of heterozygosity at multiple loci involved in cancer pathogenesis, suggesting a complex genetic background conducive to oncogenic transformation. From a phenotypic perspective, HCC1937 does not express the estrogen receptor (ER) or progesterone receptor (PR), categorizing it as ER-negative and PR-negative, which are typical markers for more aggressive disease courses. Moreover, the cells do not express Her2-neu and p53, but are positive for epithelial glycoprotein 2 (EGP2) and cytokeratin 19, which are indicative of their epithelial origin and malignant nature. The specific marker profile and genetic makeup make HCC1937 a valuable model for studying the molecular mechanisms of breast cancer and testing targeted therapies for similar aggressive breast cancer profiles. Breast cancer cell lines, Mammary gland, breast, duct, Breast ductal carcinoma, Growth Conditions: Adherent, Biosafety level: BSL 1